Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,488
Award facts
- Contract value 100% obligated
- $67,488.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,488.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for January 27, 2026. This is a non-set-aside, competitively awarded contract issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract value: $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The company serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems, with an extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. This delivery order for Cosentyx—a specialty immunosuppressant medication used in treating autoimmune conditions—reflects the company's established capability to fulfill federal medical supply requirements through open competition and demonstrates the versatility of DLA's pharmaceutical prime vendor contracting approach in meeting specialized military healthcare needs.
Quick answers
Who was awarded contract SPE2DR26F9R4E?
SPE2DR26F9R4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9R4E worth?
The government has obligated $67,488 on SPE2DR26F9R4E.
Is contract SPE2DR26F9R4E an order under another contract?
Yes. SPE2DR26F9R4E is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R4E competed?
The extent of competition for SPE2DR26F9R4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award